Emerging Research Directions Beyond the standard protocols, researchers are exploring several innovative applications: Combination with newer agents Investigating cagrilintide paired with emerging compounds like retatrutide or other multi-receptor agonists
It is also found in foods such as meats, fish, nuts, beans, spinach and eggs
CagriSema is cagrilintide + semaglutide , a fixed-dose once-weekly combination developed by Novo Nordisk and studied in the REDEFINE program ( REDEFINE 1, NCT05567796 )
Bussel JB, Arnold DM, Boxer MA, Cooper N, Mayer J, Zayed H, et al
Make an appointment with your doctor to start the discussion